he early immune response in a person who has been vaccinated for COVID-19 can predict the level of protection they will have to the virus over time, according to analysis from Australian mathematicians, clinicians, and scientists, and published today in Nature Medicine.
A collaborative project involving the University of Sydney, the Centenary Institute, the University of Technology Sydney and the Kirby Institute at UNSW.
Date Time
New COVID vaccine among recipients of funding injection The University of Sydney has received funding for 12 research projects, including a single-dose COVID vaccine, from the Medical Research Future Fund.
A single-dose vaccine that targets new COVID-19 variants has been awarded funding to fast-track testing in human trials.
The University of Sydney technology was one of 12 research projects to be awarded funding under the latest Medical Research Future Fund (MRFF) round.
Other Sydney projects that shared in the $29 million in funding will focus on child mental health and silicosis.
Deputy Vice-Chancellor (Research) Professor Duncan Ivison said Sydney dominated this round of MRFF funding.
Experts say Australia could complete vaccination program by December
Weâre sorry, this service is currently unavailable. Please try again later.
Dismiss
Save
Normal text size
Advertisement
Australia has a chance of vaccinating the entire adult population this year, as experts say a new deal for 25 million doses of Modernaâs mRNA vaccine makes a national December target reachable.
The Moderna vaccine will be used as a back-up option and as a booster for future COVID-19 variants. Ten million doses are to arrive this year and another 15 million next year.
Australia has ordered 25 million doses of the Moderna vaccine to support the national vaccination program.